Table of Content

"1    INTRODUCTION    29
1.1    OBJECTIVES OF THE STUDY    29
1.2    MARKET DEFINITION    29
1.2.1    INCLUSIONS AND EXCLUSIONS    29
1.3    MARKET SCOPE    30
1.3.1    MARKETS COVERED    30
1.3.2    MARKETS COVERED – BY REGION    30
1.3.3    YEARS CONSIDERED FOR THE STUDY    31
1.4    CURRENCY    31
TABLE 1    EXCHANGE RATES UTILIZED FOR CONVERSION TO USD    31
1.5    STAKEHOLDERS    32
1.6    SUMMARY OF CHANGES    32
2    RESEARCH METHODOLOGY    34
2.1    RESEARCH APPROACH    34
FIGURE 1    RESEARCH DESIGN    34
2.1.1    SECONDARY DATA    34
2.1.1.1    Key data from secondary sources    35
2.1.2    PRIMARY DATA    36
2.1.2.1    Primary sources    36
2.1.2.2    Key data from primary sources    37
2.1.2.3    Breakdown of primaries    37
FIGURE 2    BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION    37
FIGURE 3    BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER TYPE, DESIGNATION, AND REGION    38
2.2    MARKET SIZE ESTIMATION    38
FIGURE 4    MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2020)    39
FIGURE 5    SUPPLY-SIDE ANALYSIS: SOFT TISSUE REPAIR MARKET    40
FIGURE 6    TOP-DOWN APPROACH    41
FIGURE 7    CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS,
RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE SOFT TISSUE REPAIR MARKET (2022–2027)    42
2.3    GROWTH FORECAST    42
FIGURE 8    CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS OF THE SOFT TISSUE
REPAIR MARKET (2021)    43
2.4    MARKET BREAKDOWN & DATA TRIANGULATION    44
FIGURE 9    DATA TRIANGULATION METHODOLOGY    44
2.5    KEY INDUSTRY INSIGHTS    45

2.6    LIMITATIONS    45
2.6.1    METHODOLOGY-RELATED LIMITATIONS    45
2.7    RISK ASSESSMENT    46
2.8    ASSUMPTIONS FOR THE STUDY    46
3    EXECUTIVE SUMMARY    47
FIGURE 10    SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)    47
FIGURE 11    SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION)    48
FIGURE 12    SOFT TISSUE REPAIR MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)    48
FIGURE 13    GEOGRAPHICAL SNAPSHOT OF THE SOFT TISSUE REPAIR MARKET    49
4    PREMIUM INSIGHTS    50
4.1    SOFT TISSUE REPAIR SYSTEM MARKET OVERVIEW    50
FIGURE 14    INCREASING HERNIA CASES AND TRAUMA INJURIES AND
GROWING R&D DRIVE THE MARKET    50
4.2    REGIONAL MIX: SOFT TISSUE REPAIR MARKET    50
FIGURE 15    APAC TO REGISTER THE HIGHEST CAGR OF DURING THE FORECAST PERIOD    50
4.3    ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY PRODUCT AND COUNTRY (2021)    51
FIGURE 16    TISSUE PATCHES/MESHES ACCOUNTED FOR THE LARGEST SHARE
OF THE ASIA PACIFIC MARKET IN 2021    51
4.4    SOFT TISSUE REPAIR MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES    52
FIGURE 17    CHINA TO REGISTER THE HIGHEST REVENUE GROWTH DURING
THE FORECAST PERIOD    52
4.5    SOFT TISSUE REPAIR MARKET: DEVELOPED VS. DEVELOPING MARKETS    52
FIGURE 18    DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE
DURING THE FORECAST PERIOD    52
5    MARKET OVERVIEW    53
5.1    INTRODUCTION    53
5.2    MARKET DYNAMICS: IMPACT ANALYSIS    53
5.2.1    DRIVERS    54
5.2.1.1    Increasing aging population and obesity rate    54
5.2.1.2    Growing incidence of sports injuries    54
5.2.1.3    Strong focus on R&D    55
5.2.1.4    Increasing volume of surgeries and growing prevalence of
severe trauma injuries    55
TABLE 2    UK: INCREASE IN THE NUMBER OF CARDIAC SURGICAL
PROCEDURES PERFORMED    56
5.2.2    RESTRAINTS    57
5.2.2.1    Unfavorable reimbursement scenario    57
5.2.2.2    High product and procedure costs    57
5.2.3    OPPORTUNITIES    58
5.2.3.1    Growing adoption of advanced soft tissue repair products in emerging markets    58
TABLE 3    COST OF SURGICAL PROCEDURES: US VS. INDIA (USD)    58
5.2.3.2    Growing use of combination materials for enhancing product efficacy    59
5.2.4    CHALLENGES    59
5.2.4.1    Stringent regulatory framework    59
5.2.4.2    Need for skilled personnel    60
5.3    ASSESSMENT OF THE IMPACT OF COVID-19 ON ECONOMIC SCENARIO IN
SOFT TISSUE REPAIR MARKET    60
5.4    ECOSYSTEM ANALYSIS    61
FIGURE 19    SOFT TISSUE REPAIR MARKET: ECOSYSTEM ANALYSIS    61
5.5    PRICING ANALYSIS    62
TABLE 4    AVERAGE SELLING PRICE FOR SOFT TISSUE REPAIR PRODUCTS    62
5.6    SUPPLY CHAIN ANALYSIS    62
FIGURE 20    SUPPLY CHAIN ANALYSIS: SOFT TISSUE REPAIR MARKET (2021)    62
5.7    PATENT ANALYSIS    64
5.7.1    PATENT PUBLICATION TRENDS FOR SOFT TISSUE REPAIR MARKET    64
FIGURE 21    GLOBAL PATENT PUBLICATION TRENDS IN SOFT TISSUE REPAIR, 2016–2021    64
5.7.2    TOP APPLICANTS (COMPANIES) OF SOFT TISSUE REPAIR PATENTS    65
FIGURE 22    TOP COMPANIES THAT APPLIED FOR SOFT TISSUE REPAIR PRODUCT PATENTS, 2016–2021    65
5.7.3    JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE SOFT TISSUE REPAIR MARKET    65
FIGURE 23    JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR SOFT TISSUE REPAIR PATENTS, 2016–2021    65
5.8    VALUE CHAIN ANALYSIS    66
FIGURE 24    SOFT TISSUE REPAIR MARKET: VALUE CHAIN ANALYSIS (2021)    66
5.9    TECHNOLOGY ANALYSIS    67
5.10    KEY CONFERENCES & EVENTS IN 2022–2023    67
5.11    REGULATORY LANDSCAPE    68
TABLE 5    REGULATORY STANDARDS/APPROVALS REQUIRED FOR SOFT TISSUE
REPAIR PRODUCTS, BY COUNTRY/REGION    68
5.12    PORTER’S FIVE FORCES ANALYSIS    68
TABLE 6    SOFT TISSUE REPAIR MARKET: PORTER’S FIVE FORCES ANALYSIS    68
5.12.1    THREAT FROM NEW ENTRANTS    69
5.12.2    COMPETITIVE RIVALRY    69
5.12.3    BARGAINING POWER OF BUYERS    69
5.12.4    BARGAINING POWER OF SUPPLIERS    70
5.12.5    THREAT FROM SUBSTITUTES    70
5.13    KEY STAKEHOLDERS & BUYING CRITERIA    70
5.13.1    KEY STAKEHOLDERS IN BUYING PROCESS    70
FIGURE 25    INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS
FOR TOP 3 APPLICATIONS    70
TABLE 7    INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS
FOR TOP 3 APPLICATIONS (%)    71

5.13.2    BUYING CRITERIA    71
FIGURE 26    KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS    71
TABLE 8    KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS    72
6    SOFT TISSUE REPAIR MARKET, BY PRODUCT    73
6.1    INTRODUCTION    74
TABLE 9    SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)    74
6.2    TISSUE PATCHES/MESHES    74
TABLE 10    SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY COUNTRY, 2020–2027 (USD MILLION)    75
TABLE 11    SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)    75
6.2.1    SYNTHETIC MESHES    76
6.2.1.1    Growing popularity is attributed to the availability of raw materials, lack of infectious disease transmission, cost-effectiveness    76
TABLE 12    SOFT TISSUE REPAIR MARKET FOR SYNTHETIC MESHES, BY COUNTRY,
2020–2027 (USD MILLION)    76
6.2.2    BIOLOGICAL MESHES    77
TABLE 13    SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY COUNTRY, 2020–2027 (USD MILLION)    77
TABLE 14    SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE,
2020–2027 (USD MILLION)    78
6.2.2.1    Allografts    78
6.2.2.1.1    Biocompatibility and superior aesthetic results drive the use of allografts    78
TABLE 15    SOFT TISSUE REPAIR MARKET FOR ALLOGRAFTS, BY COUNTRY,
2020–2027 (USD MILLION)    79
6.2.2.2    Xenografts    79
6.2.2.2.1    Xenografts are more viable than allografts due to availability and size ranges    79
TABLE 16    SOFT TISSUE REPAIR MARKET FOR XENOGRAFTS, BY COUNTRY,
2020–2027 (USD MILLION)    80
6.2.3    FIXATION PRODUCTS    80
TABLE 17    SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)    81
TABLE 18    SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE,
2020–2027 (USD MILLION)    81
6.2.3.1    Suture anchors    82
6.2.3.1.1    Growing injury incidence and need for surgery drive demand for suture anchors    82
TABLE 19    SOFT TISSUE REPAIR MARKET FOR SUTURE ANCHORS, BY COUNTRY,
2020–2027 (USD MILLION)    82
6.2.3.2    Interference screws    83
6.2.3.2.1    Availability of advanced biodegradable screws and development of biocomposites drives the market growth    83
TABLE 20    SOFT TISSUE REPAIR MARKET FOR INTERFERENCE SCREWS, BY COUNTRY, 2020–2027 (USD MILLION)    83
6.2.3.3    Other fixation products    83
TABLE 21    SOFT TISSUE REPAIR MARKET FOR OTHER FIXATION PRODUCTS,
BY COUNTRY, 2020–2027 (USD MILLION)    84
6.3    LAPAROSCOPIC INSTRUMENTS    84
6.3.1    QUICK RECOVERY, LOW PAIN & INFECTION RATES DRIVE DEMAND FOR LAPAROSCOPIC SURGERY AND ASSOCIATED INSTRUMENTS    84
TABLE 22    SOFT TISSUE REPAIR MARKET FOR LAPAROSCOPIC INSTRUMENTS,
BY COUNTRY, 2020–2027 (USD MILLION)    85
7    SOFT TISSUE REPAIR MARKET, BY APPLICATION    86
7.1    INTRODUCTION    87
TABLE 23    SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)    87
7.2    HERNIA REPAIR    87
7.2.1    HERNIA REPAIR ACCOUNTS FOR THE LARGEST SHARE OF
THE SOFT TISSUE REPAIR MARKET    87
TABLE 24    SOFT TISSUE REPAIR MARKET FOR HERNIA REPAIR, BY COUNTRY,
2020–2027 (USD MILLION)    88
7.3    SKIN REPAIR    88
7.3.1    INCREASING CASES OF CHRONIC WOUNDS, DIABETIC ULCERS, AND BURNS CONTRIBUTE TO GROWTH OF SKIN REPAIR MARKET    88
TABLE 25    SOFT TISSUE REPAIR MARKET FOR SKIN REPAIR, BY COUNTRY,
2020–2027 (USD MILLION)    89
7.4    ORTHOPEDIC REPAIR    89
7.4.1    INCREASING NUMBER OF SPORTS INJURIES DRIVES
ORTHOPEDIC REPAIR MARKET    89
TABLE 26    SOFT TISSUE REPAIR MARKET FOR ORTHOPEDIC REPAIR, BY COUNTRY, 2020–2027 (USD MILLION)    90
7.5    DENTAL REPAIR    90
7.5.1    RISING DEMAND FOR PREVENTIVE AND COSMETIC DENTAL PROCEDURES DRIVES THE DENTAL REPAIR MARKET    90
TABLE 27    SOFT TISSUE REPAIR MARKET FOR DENTAL REPAIR, BY COUNTRY,
2020–2027 (USD MILLION)    91
7.6    BREAST RECONSTRUCTION    91
7.6.1    RISING BREAST CANCER PREVALENCE SUPPORTS MARKET GROWTH    91
TABLE 28    SOFT TISSUE REPAIR MARKET FOR BREAST RECONSTRUCTION, BY COUNTRY, 2020–2027 (USD MILLION)    92
7.7    DURAL REPAIR    92
7.7.1    RISING PREVALENCE OF NEUROVASCULAR DISORDERS AND AWARENESS DRIVES THE DURAL SOFT TISSUE REPAIR MARKET    92
TABLE 29    SOFT TISSUE REPAIR MARKET FOR DURAL REPAIR, BY COUNTRY,
2020–2027 (USD MILLION)    93
7.8    VAGINAL SLING PROCEDURES    93
7.8.1    DEMAND FOR VAGINAL SLING PROCEDURES BOLSTERED BY GROWING CASES OF STRESS-INDUCED URINARY INCONTINENCE (SUI) IN WOMEN    93
TABLE 30    SOFT TISSUE REPAIR MARKET FOR VAGINAL SLING PROCEDURES,
BY COUNTRY, 2020–2027 (USD MILLION)    94

7.9    OTHER APPLICATIONS    94
TABLE 31    SOFT TISSUE REPAIR MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)    95
8    SOFT TISSUE REPAIR MARKET, BY END USER    96
8.1    INTRODUCTION    97
TABLE 32    SOFT TISSUE REPAIR MARKET, BY END USER, 2020–2027 (USD MILLION)    97
8.2    HOSPITALS    97
8.2.1    HOSPITALS ARE THE LARGEST END USERS OF
SOFT TISSUE REPAIR PRODUCTS    97
TABLE 33    SOFT TISSUE REPAIR MARKET FOR HOSPITALS, BY COUNTRY,
2020–2027 (USD MILLION)    98
8.3    CLINICS    98
8.3.1    QUICKER CONSULTATION SERVICES AND MINIMAL PATIENT STAYS ARE ADVANTAGES OFFERED BY CLINICS OVER HOSPITALS    98
TABLE 34    SOFT TISSUE REPAIR MARKET FOR CLINICS, BY COUNTRY,
2020–2027(USD MILLION)    99
8.4    OTHER END USERS    99
TABLE 35    SOFT TISSUE REPAIR MARKET FOR OTHER END USERS, BY COUNTRY,
2020–2027 (USD MILLION)    100
9    SOFT TISSUE REPAIR MARKET, BY REGION    101
9.1    INTRODUCTION    102
FIGURE 27    INDIA AND CHINA TO REGISTER HIGHEST GROWTH RATES IN THE
SOFT TISSUE REPAIR MARKET    102
TABLE 36    SOFT TISSUE REPAIR MARKET, BY REGION, 2020–2027 (USD MILLION)    102
9.2    NORTH AMERICA    103
FIGURE 28    NORTH AMERICA: SOFT TISSUE REPAIR MARKET SNAPSHOT    104
TABLE 37    NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY COUNTRY,
2020–2027 (USD MILLION)    104
TABLE 38    NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION)    105
TABLE 39    NORTH AMERICA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)    105
TABLE 40    NORTH AMERICA: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)    105
TABLE 41    NORTH AMERICA: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)    106
TABLE 42    NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION)    106
TABLE 43    NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION)    107
9.2.1    US    107
9.2.1.1    Presence of prominent market players and high per capita income supports market growth in the US    107
TABLE 44    US: MACROECONOMIC INDICATORS    107
TABLE 45    US: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)    108
TABLE 46    US: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)    108
TABLE 47    US: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)    108
TABLE 48    US: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE,
2020–2027 (USD MILLION)    109
TABLE 49    US: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION)    109
TABLE 50    US: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION)    109
9.2.2    CANADA    110
9.2.2.1    Rising healthcare expenditure and favorable public and private funding supports soft tissue repair market growth    110
TABLE 51    CANADA: MACROECONOMIC INDICATORS    110
TABLE 52    CANADA: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION)    110
TABLE 53    CANADA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES,
BY TYPE, 2020–2027 (USD MILLION)    111
TABLE 54    CANADA: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)    111
TABLE 55    CANADA: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)    111
TABLE 56    CANADA: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION)    112
TABLE 57    CANADA: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION)    112
9.3    EUROPE    112
FIGURE 29    EUROPE: SOFT TISSUE REPAIR MARKET SNAPSHOT    113
TABLE 58    EUROPE: SOFT TISSUE REPAIR MARKET, BY COUNTRY,
2020–2027 (USD MILLION)    114
TABLE 59    EUROPE: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION)    114
TABLE 60    EUROPE: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES,
BY TYPE, 2020–2027 (USD MILLION)    114
TABLE 61    EUROPE: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)    115
TABLE 62    EUROPE: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)    115
TABLE 63    EUROPE: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION)    115
TABLE 64    EUROPE: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION)    116
9.3.1    GERMANY    116
9.3.1.1    Germany holds the largest share of the European market    116
TABLE 65    GERMANY: MACROECONOMIC INDICATORS    116
TABLE 66    GERMANY: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION)    117
TABLE 67    GERMANY: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES,
BY TYPE, 2020–2027 (USD MILLION)    117
TABLE 68    GERMANY: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES,
BY TYPE, 2020–2027 (USD MILLION)    117
TABLE 69    GERMANY: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)    118
TABLE 70    GERMANY: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION)    118
TABLE 71    GERMANY: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION)    118
9.3.2    FRANCE    119
9.3.2.1    Presence of a well-established healthcare system and growing geriatric population to boost the market growth    119
TABLE 72    FRANCE: MACROECONOMIC INDICATORS    119
TABLE 73    FRANCE: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION)    119
TABLE 74    FRANCE: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES,
BY TYPE, 2020–2027 (USD MILLION)    120
TABLE 75    FRANCE: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)    120
TABLE 76    FRANCE: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)    120
TABLE 77    FRANCE: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION)    121
TABLE 78    FRANCE: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION)    121
9.3.3    UK    121
9.3.3.1    Growing volume of hernia repair surgeries and cardiovascular surgeries in the UK stimulating market growth    121
TABLE 79    UK: MACROECONOMIC INDICATORS    122
TABLE 80    UK: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)    122
TABLE 81    UK: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)    122
TABLE 82    UK: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)    123
TABLE 83    UK: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE,
2020–2027 (USD MILLION)    123
TABLE 84    UK: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION)    123
TABLE 85    UK: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION)    124
9.3.4    ITALY    124
9.3.4.1    Increasing volume of surgeries to drive the demand for soft tissue repair products in the country    124
TABLE 86    ITALY: MACROECONOMIC INDICATORS    124
TABLE 87    ITALY: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION)    125
TABLE 88    ITALY: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES,
BY TYPE, 2020–2027 (USD MILLION)    125
TABLE 89    ITALY: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)    125
TABLE 90    ITALY: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)    126
TABLE 91    ITALY: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION)    126
TABLE 92    ITALY: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION)    126
9.3.5    SPAIN    127
9.3.5.1    Growing healthcare budget and rising efforts for boosting the local manufacturing of medical products to drive market growth    127
TABLE 93    SPAIN: MACROECONOMIC INDICATORS    127
TABLE 94    SPAIN: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION)    128
TABLE 95    SPAIN: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES,
BY TYPE, 2020–2027 (USD MILLION)    128
TABLE 96    SPAIN: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)    128
TABLE 97    SPAIN: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)    129
TABLE 98    SPAIN: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION)    129
TABLE 99    SPAIN: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION)    129
9.3.6    REST OF EUROPE    130
TABLE 100    ROE: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION)    130
TABLE 101    ROE: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)    131
TABLE 102    ROE: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)    131
TABLE 103    ROE: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)    131
TABLE 104    ROE: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION)    132
TABLE 105    ROE: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION)    132
9.4    ASIA PACIFIC    132
FIGURE 30    ASIA PACIFIC: SOFT TISSUE REPAIR MARKET SNAPSHOT    133
TABLE 106    APAC: SOFT TISSUE REPAIR MARKET, BY COUNTRY,
2020–2027 (USD MILLION)    134
TABLE 107    APAC: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION)    134
TABLE 108    APAC: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES,
BY TYPE, 2020–2027 (USD MILLION)    134
TABLE 109    APAC: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)    135
TABLE 110    APAC: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)    135
TABLE 111    APAC: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION)    135
TABLE 112    APAC: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION)    136
9.4.1    JAPAN    136
9.4.1.1    Strong healthcare system and rising geriatric population to support market growth in Japan    136
TABLE 113    JAPAN: MACROECONOMIC INDICATORS    137
TABLE 114    JAPAN: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION)    137
TABLE 115    JAPAN: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES,
BY TYPE, 2020–2027 (USD MILLION)    137
TABLE 116    JAPAN: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)    138
TABLE 117    JAPAN: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)    138
TABLE 118    JAPAN: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION)    138
TABLE 119    JAPAN: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION)    139
9.4.2    CHINA    139
9.4.2.1    Growing number of hospitals and healthcare policy reforms stimulating market growth    139
TABLE 120    CHINA: MACROECONOMIC INDICATORS    140
TABLE 121    CHINA: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION)    140
TABLE 122    CHINA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES,
BY TYPE, 2020–2027 (USD MILLION)    140
TABLE 123    CHINA: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)    141
TABLE 124    CHINA: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)    141
TABLE 125    CHINA: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION)    141
TABLE 126    CHINA: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION)    142
9.4.3    INDIA    142
9.4.3.1    Rising healthcare awareness and favorable government support to stimulate market growth in India    142
TABLE 127    INDIA: MACROECONOMIC INDICATORS    143
TABLE 128    INDIA: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION)    143
TABLE 129    INDIA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES,
BY TYPE, 2020–2027 (USD MILLION)    143
TABLE 130    INDIA: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)    144
TABLE 131    INDIA: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)    144
TABLE 132    INDIA: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION)    144
TABLE 133    INDIA: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION)    145
9.4.4    REST OF ASIA PACIFIC    145
TABLE 134    ROAPAC: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION)    145
TABLE 135    ROAPAC: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES,
BY TYPE, 2020–2027 (USD MILLION)    146
TABLE 136    ROAPAC: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)    146
TABLE 137    ROAPAC: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)    146
TABLE 138    ROAPAC: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION)    147
TABLE 139    ROAPAC: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION)    147
9.5    LATIN AMERICA    147
9.5.1    LOW-COST SURGERIES ATTRACT MEDICAL TOURISTS TO LATIN AMERICA    147
TABLE 140    LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION)    148
TABLE 141    LATIN AMERICA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)    148
TABLE 142    LATIN AMERICA: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)    148
TABLE 143    LATIN AMERICA: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS,
BY TYPE, 2020–2027 (USD MILLION)    149
TABLE 144    LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION)    149
TABLE 145    LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION)    150
9.6    MIDDLE EAST & AFRICA    150
9.6.1    MEA IS THE SMALLEST REGIONAL MARKET FOR BIOSURGERY PRODUCTS    150
TABLE 146    MEA: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION)    151
TABLE 147    MEA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES,
BY TYPE, 2020–2027 (USD MILLION)    151
TABLE 148    MEA: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)    151
TABLE 149    MEA: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)    152
TABLE 150    MEA: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION)    152
TABLE 151    MEA: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION)    152

10    COMPETITIVE LANDSCAPE    153
10.1    OVERVIEW    153
10.2    KEY PLAYER STRATEGIES/RIGHT TO WIN    153
10.3    REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS    154
FIGURE 31    REVENUE ANALYSIS OF THE TOP PLAYERS IN THE
SOFT TISSUE REPAIR MARKET    154
10.4    MARKET SHARE ANALYSIS    155
FIGURE 32    SOFT TISSUE REPAIR MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020    155
10.5    COMPANY EVALUATION QUADRANT    156
10.5.1    STARS    156
10.5.2    PERVASIVE PLAYERS    156
10.5.3    EMERGING LEADERS    157
10.5.4    PARTICIPANTS    157
FIGURE 33    SOFT TISSUE REPAIR MARKET: COMPANY EVALUATION MATRIX, 2021    157
10.6    COMPETITIVE LEADERSHIP MAPPING FOR SMES & START-UPS    158
10.6.1    PROGRESSIVE COMPANIES    158
10.6.2    DYNAMIC COMPANIES    158
10.6.3    STARTING BLOCKS    158
10.6.4    RESPONSIVE COMPANIES    158
FIGURE 34    SOFT TISSUE REPAIR MARKET: COMPANY EVALUATION MATRIX
FOR SMES & START-UP    159
10.7    COMPETITIVE BENCHMARKING    160
10.7.1    OVERALL COMPANY FOOTPRINT    160
TABLE 152    OVERALL COMPANY FOOTPRINT (25 COMPANIES)    160
TABLE 153    COMPANY FOOTPRINT: BY PRODUCT (25 COMPANIES)    161
TABLE 154    COMPANY FOOTPRINT: BY APPLICATION (25 COMPANIES)    162
TABLE 155    COMPANY FOOTPRINT: BY REGION (25 COMPANIES)    163
10.8    COMPETITIVE SCENARIO    165
10.8.1    DEALS    165
TABLE 156    DEALS    165
10.8.2    OTHER DEVELOPMENTS    166
TABLE 157    OTHER DEVELOPMENTS    166
11    COMPANY PROFILES    167
(Business Overview, Products Offered, Recent Developments, and MnM View)*
11.1    KEY PLAYERS    167
11.1.1    ARTHREX INC.    167
TABLE 158    ARTHREX INC.: BUSINESS OVERVIEW    167
11.1.2    SMITH & NEPHEW PLC    169
TABLE 159    SMITH & NEPHEW PLC: BUSINESS OVERVIEW    169
FIGURE 35    SMITH & NEPHEW PLC: COMPANY SNAPSHOT (2020)    170
11.1.3    JOHNSON & JOHNSON    173
TABLE 160    JOHNSON & JOHNSON: BUSINESS OVERVIEW    173
FIGURE 36    JOHNSON & JOHNSON: COMPANY SNAPSHOT (2020)    174
11.1.4    BECTON, DICKINSON & COMPANY    177
TABLE 161    BECTON, DICKINSON & COMPANY: BUSINESS OVERVIEW    177
FIGURE 37    BECTON, DICKINSON & COMPANY: COMPANY SNAPSHOT (2020)    177
11.1.5    STRYKER CORPORATION    181
TABLE 162    STRYKER CORPORATION: BUSINESS OVERVIEW    181
FIGURE 38    STRYKER CORPORATION: COMPANY SNAPSHOT (2020)    182
11.1.6    MEDTRONIC PLC.    184
TABLE 163    MEDTRONIC PLC.: BUSINESS OVERVIEW    184
FIGURE 39    MEDTRONIC PLC.: COMPANY SNAPSHOT (2020)    185
11.1.7    ZIMMER BIOMET    188
TABLE 164    ZIMMER BIOMET: BUSINESS OVERVIEW    188
FIGURE 40    ZIMMER BIOMET: COMPANY SNAPSHOT (2020)    189
11.1.8    INTEGRA LIFESCIENCES HOLDINGS CORPORATION    191
TABLE 165    INTEGRA LIFESCIENCES HOLDINGS CORPORATION: BUSINESS OVERVIEW    191
FIGURE 41    INTEGRA LIFESCIENCES HOLDINGS CORPORATION:
COMPANY SNAPSHOT (2020)    192
11.1.9    CRYOLIFE INC.    194
TABLE 166    CRYOLIFE INC.: BUSINESS OVERVIEW    194
FIGURE 42    CRYOLIFE INC.: COMPANY SNAPSHOT (2020)    195
11.1.10    ORGANOGENESIS INC.    197
TABLE 167    ORGANOGENESIS INC.: BUSINESS OVERVIEW    197
FIGURE 43    ORGANOGENESIS INC.: COMPANY SNAPSHOT (2020)    197
11.2    OTHER PLAYERS    199
11.2.1    LIFENET HEALTH INC.    199
TABLE 168    LIFENET HEALTH INC.: BUSINESS OVERVIEW    199
11.2.2    BAXTER INTERNATIONAL, INC.    201
TABLE 169    BAXTER INTERNATIONAL, INC.: BUSINESS OVERVIEW    201
FIGURE 44    BAXTER INTERNATIONAL: COMPANY SNAPSHOT (2020)    202
11.2.3    TISSUE REGENIX GROUP PLC    204
TABLE 170    TISSUE REGENIX GROUP PLC: BUSINESS OVERVIEW    204
FIGURE 45    TISSUE REGENIX GROUP PLC: COMPANY SNAPSHOT (2020)    204
11.2.4    CONMED CORPORATION    207
TABLE 171    CONMED CORPORATION: BUSINESS OVERVIEW    207
FIGURE 46    CONMED CORPORATION: COMPANY SNAPSHOT (2020)    208
11.2.5    MERIL LIFE SCIENCES PVT. LTD.    210
TABLE 172    MERIL LIFE SCIENCES PVT. LTD.: BUSINESS OVERVIEW    210
11.2.6    RTI SURGICAL    211
TABLE 173    RTI SURGICAL: BUSINESS OVERVIEW    211
11.2.7    SAMYANG HOLDINGS CORPORATION    212
TABLE 174    SAMYANG HOLDINGS CORPORATION: BUSINESS OVERVIEW    212
11.2.8    AROA BIOSURGERY LTD.    213
TABLE 175    AROA BIOSURGERY LTD.: BUSINESS OVERVIEW    213
11.2.9    ACERA SURGICAL INC.    214
TABLE 176    ACERA SURGICAL INC.: BUSINESS OVERVIEW    214
11.2.10    ORTHOCELL LTD.    215
TABLE 177    ORTHOCELL LTD.: BUSINESS OVERVIEW    215
11.2.11    ACELL INC.    216
TABLE 178    ACELL INC.: BUSINESS OVERVIEW    216
11.2.12    BIOCER ENTWICKLUNGS-GMBH    217
TABLE 179    BIOCER ENTWICKLUNGS-GMBH: BUSINESS OVERVIEW    217
11.2.13    ISTO BIOLOGICS    218
TABLE 180    ISTO BIOLOGICS: BUSINESS OVERVIEW    218
11.2.14    BETATECH MEDICAL    219
TABLE 181    BETATECH MEDICAL: BUSINESS OVERVIEW    219
11.2.15    MIMEDX    220
TABLE 182    MIMEDX: BUSINESS OVERVIEW    220
FIGURE 47    MIMEDX: COMPANY SNAPSHOT (2020)    220
* Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
12    APPENDIX    222
12.1    INDUSTRY INSIGHTS    222
12.2    DISCUSSION GUIDE    223
12.3    KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL    226
12.4    AVAILABLE CUSTOMIZATIONS    228
12.5    RELATED REPORTS    228
12.6    AUTHOR DETAILS    229"